New Study Confirms: FDA Medical Device Approval Process Flawed | Law Firm Newswire

New Study Confirms: FDA Medical Device Approval Process Flawed

Houston, TX (Law Firm Newswire) December 30, 2014 - Studies are again criticizing the Food and Drug Administration (FDA), saying its fast-track process for medical devices approves many that do not meet regulatory standards.

The National Center for Health Research reports that a worrying majority of medical devices approved under the FDA’s fast-track process lack publicly available safety documentation. Without this documentation, doctors and hospitals cannot accurately assess the risk a device poses to patients.

“The FDA gets a lot of pressure from medical device companies that want to beat the competition to market,” commented Richard LaGarde, a defective products attorney. “Sadly, despite previous warnings on this issue, this new study shows that the FDA is still doing a poor job of putting patient safety first.”

Previously, a major study called the FDA’s fast-track medical device approval process “fatally flawed.” That study, published in 2011, attributed a growing number of device failures and recalls to inadequate testing, according to Reuters.

The FDA commissioned the 2011 report after major headlines brought publicity to a number of massive medical device recalls.

But upon receipt of the 2011 report, the FDA immediately rejected the findings and continued using the controversial fast-track approval process with few improvements. Last month, FDA officials announced at a medical device conference that they would be searching for ways to make the medical device approval process even faster.

The latest study from the National Center for Health Research looked at more than a thousand devices approved under the fast-track process, and found that 84 percent lacked publicly-available documentation showing why the device should be considered safe.

“At the end of the day, the manufacturer is responsible for ensuring that the device is safe,” said LaGarde. “Nonetheless, it is frightening to know how easy it is for a company to have a device declared safe by the FDA, even when the device does not meet the FDA’s own standards.”

Currently, most medical devices are approved under the fast-track process.

LaGarde Law Firm, P.C
3000 Weslayan, Ste. 380
Houston, TX 77027
Phone: (713) 993-0660
Toll Free: 1-866-LAGARDE

LaGarde Law Firm, P.C.
Jason M. Welborn - Of Counsel
617 S. Buchanan Street
PO Box 2053
Lafayette, LA 70501
Phone: (337) 443-4100
Toll Free: 1-866-LAGARDE

facebook twitter google_plus_32

  • Supreme Court Orders Oral Arguments in Fun 5’s Lawsuit
    The Texas Supreme Court issued an order this morning requiring the attorneys who represent the lottery players and the attorneys who represent GTECH (now known as IGT) to appear before the Court on December 3, 2019 to present oral arguments. The oral arguments will be videotaped and will be available for the public to watch […]
  • Status of Fun 5’s Lawsuit
    Q: What is the status of the Fun 5’s Lawsuit? A: The Fun 5’s Lawsuit against GTECH, Inc. (now known as IGT) is currently pending before the Texas Supreme Court. GTECH argued in the trial court that it is immune from suit for fraud because it was working for the Texas Lottery Commission. The lottery […]
  • Benzene Spike Near Houston Chemical Plant Fire Causes Me Concern About Future Leukemia Cases
    Having survived a battle with Leukemia, I am concerned by the latest report in the Houston Chronicle that a spike in benzene levels has been detected near the Deer Park site of the ITC chemical plant fire. Benzene is a major cause of leukemia which is a cancer of the bone marrow. Leukemia is a […]
  • GTECH Files Reply Brief in Fun 5’s Case
    GTECH filed its Reply Brief on the Merits in the Fun 5’s scratch-off lottery ticket lawsuit currently pending before the Texas Supreme Court. Now that all the briefs have been filed in Steele et al. v. GTECH, the Supreme Court is likely to take one of two steps. It may either deny GTECH’s Petition for […]
  • Plaintiffs in Fun 5’s Lawsuit File Their Brief on the Merits
    Plaintiffs in the Fun 5’s lawsuit in Texas filed their Respondents’ Brief on the Merits  today.  In their 61 page brief, attorneys for the Plaintiffs argue that GTECH (now known as IGT) is not entitled to derivative sovereign immunity.  GTECH claims it was just following orders when it printed scratch-off lottery tickets with instructions that falsely […]

See other news sources publishing this article. BETA | Tags: , , , , ,



Get headlines from Law Firm Newswire sent right to your inbox.

* indicates required